EG243302 Inhibitors
EG243302 inhibitors are a class of chemical compounds designed to specifically block the activity of the **EG243302** protein, a molecule likely involved in essential cellular processes such as signal transduction, enzymatic regulation, or molecular transport. These inhibitors work by binding to key sites on the EG243302 protein, preventing it from interacting with other molecules or carrying out its intended function within the cell. By inhibiting EG243302, researchers can study how its absence impacts various cellular pathways, such as those related to energy metabolism, protein synthesis, or intracellular communication. The disruption caused by these inhibitors allows scientists to gain insights into the biological significance of EG243302 in maintaining the functionality and balance of complex cellular networks.
The study of EG243302 inhibitors provides a deeper understanding of how this protein influences molecular processes within cells. By blocking its activity, researchers can observe downstream changes in related pathways and determine how EG243302 interacts with other proteins or enzymes. This can lead to the identification of compensatory mechanisms or shifts in cellular regulation that arise when EG243302 is not functioning properly. Moreover, the use of these inhibitors offers insights into the feedback loops and signaling pathways that involve EG243302, allowing researchers to map out its role in maintaining cellular homeostasis. Through these detailed investigations, EG243302 inhibitors serve as valuable tools for uncovering the molecular dynamics and regulatory functions that underpin key cellular activities, shedding light on the broader biological role of this protein in various systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase (HDAC) inhibitor impacting Gm4963's transcription repressor activity. Trichostatin A alters chromatin structure, influencing RNA polymerase II-specific DNA binding and the regulation of gene expression within the nucleolus and nucleoplasm. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 mitogen-activated protein kinase (MAPK) inhibitor affecting Gm4963's role in the regulation of cysteine-type endopeptidase activity. SB203580 disrupts the p38 MAPK pathway, modulating Gm4963's involvement in the innate immune response. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor impacting Gm4963's DNA-binding transcription repressor activity. 5-Azacytidine disrupts DNA methylation, altering the cis-regulatory region sequence-specific DNA binding activity of Gm4963 and influencing its role in gene expression regulation within the nucleolus and nucleoplasm. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
BET bromodomain inhibitor affecting Gm4963's transcription repressor activity. JQ1 modulates chromatin structure, influencing RNA polymerase II-specific DNA binding and the regulation of gene expression within the nucleolus and nucleoplasm. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB inhibitor impacting Gm4963's involvement in the innate immune response. BAY 11-7082 influences the nucleoplasmic activities of Gm4963, disrupting its role in the regulation of innate immune responses and cysteine-type endopeptidase activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor impacting Gm4963's regulation of cysteine-type endopeptidase activity. Rapamycin disrupts the mTOR pathway, modulating Gm4963's involvement in the innate immune response. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor impacting Gm4963's role in the regulation of gene expression. PD98059 disrupts the MAPK/ERK pathway, modulating Gm4963's RNA polymerase II-specific DNA binding activity and the regulation of gene expression within the nucleolus and nucleoplasm. | ||||||
A77 1726 | 163451-81-8 | sc-207235 | 10 mg | $78.00 | 14 | |
Janus kinase (JAK) inhibitor affecting Gm4963's participation in the regulation of innate immune responses. A771726 modulates JAK/STAT signaling, influencing Gm4963's involvement in the innate immune response and cysteine-type endopeptidase activity. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Cereblon binder impacting Gm4963's transcriptional repression. Thalidomide modulates the CUL4-CRBN E3 ubiquitin ligase complex, leading to degradation of Gm4963 and its reduced involvement in the regulation of gene expression within the nucleolus and nucleoplasm. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor impacting Gm4963's role in the regulation of cysteine-type endopeptidase activity. SP600125 disrupts the JNK signaling pathway, modulating Gm4963's involvement in the innate immune response. | ||||||